TABLE 5

IC50 values obtained for a series of compounds in different CYP3A4 assays


Compound

Fluorescent Probe in Intact Cells

Conventional Probe in Liver Microsomes
IC50a
Type of Inhibitorb
IC50
Type of Inhibitor
Ketoconazole <0.3 potent <0.3 potent
Cyclosporine 1.5 potent 20.0 moderate
Nifedipine 6.7 moderate 2.8 potent
Quercetin 34.2 poor 20.1 moderate
Verapamil 42.3 poor 35.6 poor
Omeprazole 83.5 poor 104 poor
Amiodarone 136 poor 237 poor
Sulfaphenazole 152 poor 238 poor
Ticlopidine 162 poor 148 poor
Erythromycin 170 poor 196 poor
Tranylcypromine 235 poor 208 poor
Quinine 254 poor 172 poor
Cimetidine 274 poor 300 poor
Lovastatin >300 noninhibitor 88.0 poor
Quinidine >300 noninhibitor 283 poor
Diethyldithiocarbamate >300 noninhibitor >300 noninhibitor
Furafylline
>300
noninhibitor
>300
noninhibitor
  • a IC50 (μM) data are the mean of two independent assays

  • b The compounds were classified as potent (IC50 <3 μM), moderate (IC50 from 3 to 30 μM), poor (IC50 from 30 to 300 μM), or noninhibitors (IC50 >300 μM)